COMPANY PROFILE
LIST OF DIRECTORS
TADASHI HASHIMOTO
CHIEF EXECUTIVE OFFICER
His professional experience includes being the vice president and president in Otsuka Pharmaceutical Co., Ltd. and Coca-Cola (Japan) Company Limited. Later, he founded Theravalues Corporation, where he served as president for 10 years.
ATSUSHI IMAIZUMI, Ph.D.
Advisor
After getting a position in Teijin Limited, he was a board member of Teijin Pharma Limited and he engaged in the research and development of medicines. After leaving Teijin Pharma Limited, he joined Theravalues Corporation as the Vice President and served as CSO.
YASUHIRO KATSUURA
Director
He was responsible for many pharmacological research and clinical development projects at Showa Denko K.K. and Teijin Limited, where he oversaw and led pharmaceutical research and development operations as Laboratory Director and Clinical Development Manager.
MASASHI ITOH
Director
He worked at Merchian Corporation and Japan Microbiome Pharma, Inc., to develop natural product drug discovery and processes for discovery of microbial pharmaceutical ingredients.
SCIENTIFIC ADVISORS
HIDEAKI KAKEYA, Ph.D.
Professor of Department of System Chemotherapy & Molecular Sciences, Division of Bioinformatics and Chemical Genomics, Graduate School of Pharmaceutical Sciences, Kyoto University
MASASHI KANAI, MD., Ph.D.
Professor, Cancer Center,
Kansai Medical University Hospital
PURPOSE
The research and the development of functional materials, pharmaceutical products for treatments, and diagnostic systems.
ESTABLISHED
August 2016
HEADQUARTERS
Kanagawa prefecture Kawasaki city Takatsu-ku Sakado 3-2-1
KSP Innovation Center Bldg. East 604 (lab space)
West 4F Neo G5 (office space)
Phone : +81-44-322-0005
FAX : +81-44-322-0007
ORGANIZATION SCHEME
ABOUT OUR OFFICE
THERABIOPHARMA
Kanagawa Science Park (KSP) is the first urban-type science park in Japan. It is located in an area where high tech companies and research institutes are concentrated, about 20 minutes from central Tokyo. Its scale is the largest in Japan, since it has a buildable surface area of 55.000 m2 and about 4.500 employees.
In its facilities, companies of the fields of biotechnology, information and communications technology, semiconductor, electronic and mechatronics engineering, etc. are engaged in the research and development of the latest technology. Many companies, from entrepreneurial companies to large companies, which are also expanding their business overseas, have chosen Kanagawa Science Park as their place of business.
In this KSP, Therabiopharma has now two different spaces such as:
Lab space: Innovation Bldg. East 604
Office space: Innovation Bldg. West 4F neo G5